Recombinant tissue plasminogen activator (rt-PA) is an approved intravenous thrombolytic agent used to treat acute ischemic stroke (AIS) (Paul and Candelario-Jalil, 2021). This evidence concerns the gene PLAT and androgen insensitivity syndrome.